Rongwen Bian

1.3k total citations
22 papers, 295 citations indexed

About

Rongwen Bian is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Rongwen Bian has authored 22 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Rongwen Bian's work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Rongwen Bian is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Treatment and Management (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Rongwen Bian collaborates with scholars based in China, Hong Kong and France. Rongwen Bian's co-authors include Qinglin Lou, Haidi Wu, Jie Wang, Juliana C.N. Chan, Wing‐Yee So, Chun‐Chung Chow, Wei Wang, Ronald C.W., Alice P.S. Kong and Bing Lu and has published in prestigious journals such as Ecotoxicology and Environmental Safety, Diabetes Obesity and Metabolism and Health and Quality of Life Outcomes.

In The Last Decade

Rongwen Bian

22 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongwen Bian China 11 99 75 50 41 37 22 295
Jennifer Ennis United States 7 59 0.6× 150 2.0× 29 0.6× 41 1.0× 37 1.0× 14 316
Qinglin Lou China 9 86 0.9× 109 1.5× 66 1.3× 22 0.5× 51 1.4× 14 227
Tae‐Hwa Go South Korea 9 67 0.7× 28 0.4× 38 0.8× 20 0.5× 19 0.5× 34 228
Peter Mrak Austria 8 168 1.7× 59 0.8× 28 0.6× 13 0.3× 40 1.1× 13 305
Najlaa A. Ahmad Saudi Arabia 8 273 2.8× 73 1.0× 100 2.0× 30 0.7× 22 0.6× 8 493
Kevin M. Wheelock United States 11 68 0.7× 71 0.9× 39 0.8× 46 1.1× 16 0.4× 16 313
Kazuko Ichikawa Japan 7 138 1.4× 79 1.1× 124 2.5× 23 0.6× 9 0.2× 10 412
Yingjie Su China 10 36 0.4× 41 0.5× 110 2.2× 27 0.7× 12 0.3× 34 241
Anne Haaber Denmark 10 38 0.4× 36 0.5× 60 1.2× 50 1.2× 20 0.5× 14 374
Sheryl F. Vondracek United States 12 39 0.4× 20 0.3× 35 0.7× 46 1.1× 71 1.9× 24 385

Countries citing papers authored by Rongwen Bian

Since Specialization
Citations

This map shows the geographic impact of Rongwen Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongwen Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongwen Bian more than expected).

Fields of papers citing papers by Rongwen Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongwen Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongwen Bian. The network helps show where Rongwen Bian may publish in the future.

Co-authorship network of co-authors of Rongwen Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Rongwen Bian. A scholar is included among the top collaborators of Rongwen Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongwen Bian. Rongwen Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bian, Rongwen, et al.. (2021). Association of Helicobacter pylori infection with colorectal adenoma in the Chinese urban population: A cross-sectional study. Microbial Pathogenesis. 158. 105111–105111. 5 indexed citations
2.
Wang, Wei, et al.. (2020). Association between regular aerobic exercise and hyperhomocysteine in hypertensive patients. Postgraduate Medicine. 132(5). 458–464. 2 indexed citations
4.
Bian, Rongwen, et al.. (2019). Chronic exposure to microcystin-LR reduces thyroid hormone levels by activating p38/MAPK and MEK/ERK signal pathway. Ecotoxicology and Environmental Safety. 173. 142–148. 23 indexed citations
6.
Jiang, Qi, Linlin Ji, Yuan-ye Qiu, et al.. (2019). A randomised controlled trial of stepwise sputum collection to increase yields of confirmed tuberculosis. The International Journal of Tuberculosis and Lung Disease. 23(6). 685–691. 9 indexed citations
7.
Zhu, Jun, Wei Wang, Richard Cooper, et al.. (2018). The Association Between Tea Consumption and Hyperhomocysteine in Chinese Hypertensive Patients. American Journal of Hypertension. 32(2). 209–215. 8 indexed citations
10.
Wu, Haidi, et al.. (2017). Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diabetes and Vascular Disease Research. 14(3). 221–225. 52 indexed citations
11.
12.
Shan, Shan, et al.. (2015). Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study. Clinical and Experimental Medicine. 17(1). 79–84. 19 indexed citations
13.
Ko, Gary T.C., et al.. (2015). Anthropometric parameters and their associations with cardio-metabolic risk in Chinese working population. Diabetology & Metabolic Syndrome. 7(1). 37–37. 12 indexed citations
14.
Lou, Qinglin, et al.. (2015). Lack of association between anemia and renal disease progression in Chinese patients with type 2 diabetes. Journal of Diabetes Investigation. 7(1). 42–47. 10 indexed citations
15.
Yang, Wenying, Yukun Li, Qīng Wáng, et al.. (2014). Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study. Health and Quality of Life Outcomes. 12(1). 137–137. 12 indexed citations
16.
Gu, Liubao, et al.. (2014). Mechanisms of cordycepin on improving renal interstitial fibrosis via regulating eIF2α/TGF-β/Smad signaling pathway. China Journal of Chinese Materia Medica. 39(21). 4096–101. 1 indexed citations
17.
Lou, Qinglin, Ronald C.W., Alice P.S. Kong, et al.. (2012). Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes. Diabetes & Metabolism Journal. 36(6). 433–433. 28 indexed citations
18.
Wang, Jie, et al.. (2011). Validation of the Chinese version of the Walking Impairment Questionnaire in patients with both peripheral arterial disease and type 2 diabetes mellitus. Diabetes and Vascular Disease Research. 8(1). 29–34. 13 indexed citations
19.
Lou, Qinglin, Alice P.S. Kong, Wing‐Yee So, et al.. (2010). Cardiovascular disease risk factors are highly prevalent in the office-working population of Nanjing in China. International Journal of Cardiology. 155(2). 212–216. 15 indexed citations
20.
Wang, Aihong, Shi Zhao, Qiang Li, et al.. (2007). [The medical cost of diabetic patients with foot problems due to peripheral artery disease].. PubMed. 46(6). 471–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026